Rifaximin: Phase III study update

Salix Pharmaceuticals Ltd. (TSE:SLX), Palo Alto, Calif. Product: Rifaximin Business: Infectious diseases Therapeutic category: Bacterial infection Target: Bacterial RNA polymerase Description: Broad...